Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Clinical trial NCT01105429 · COMPLETED

Trial details

NCT number: NCT01105429
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2010-05-01
Primary completion: 2010-10-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.